| 1 |
2023 |
Camille A McAloney, Rawan Makkawi, Yogesh Budhathoki, Matthew V Cannon, Emily M Franz, Amy C Gross, Maren Cam, Tatyana A Vetter, Rebekka Duhen, Alexander E Davies, Ryan D Roberts. 2023;
https://doi.org/10.21203/rs.3.rs-3129411/v1 |
| 2 |
2025 |
Anne-Sophie Becker, Friederike Klauk, Thomas Freitag, Daniel Fabian Strüder, Björn Schneider, Annette Zimpfer, Claudia Maletzki. Inhibition of platin-induced BCL2 increase overcomes chemoresistance in squamous cell carcinoma of the head and neck through resensitization to cell death, Translational Oncology. 2025; 53: 102308102308.
https://doi.org/10.1016/j.tranon.2025.102308 |
| 3 |
2022 |
Nicolas Thomas Iannozzi, Valentina Marchica, Denise Toscani, Jessica Burroughs Garcìa, Nicola Giuliani, Paola Storti. Molecular Features of the Mesenchymal and Osteoblastic Cells in Multiple Myeloma, International Journal of Molecular Sciences. 2022; 23: 15448.
https://doi.org/10.3390/ijms232415448 |
| 4 |
2024 |
Vincenzo Raimondi, Rosanna Vescovini, Mattia Dessena, Gaetano Donofrio, Paola Storti, Nicola Giuliani. Oncolytic viruses: a potential breakthrough immunotherapy for multiple myeloma patients, Frontiers in Immunology. 2024; 15: 1483806.
https://doi.org/10.3389/fimmu.2024.1483806 |
| 5 |
2024 |
Camille A. McAloney, Rawan Makkawi, Yogesh Budhathoki, Matthew V. Cannon, Emily M. Franz, Amy C. Gross, Maren Cam, Tatyana A. Vetter, Rebekka Duhen, Alexander E. Davies, Ryan D. Roberts. Host-derived growth factors drive ERK phosphorylation and MCL1 expression to promote osteosarcoma cell survival during metastatic lung colonization, Cellular Oncology. 2024; 47: 259.
https://doi.org/10.1007/s13402-023-00867-w |
| 6 |
2024 |
Mohamed H. Elbahoty, Bhavyasree Papineni, Rajeev S. Samant. Multiple myeloma: clinical characteristics, current therapies and emerging innovative treatments targeting ribosome biogenesis dynamics, Clinical & Experimental Metastasis. 2024; 41: 829.
https://doi.org/10.1007/s10585-024-10305-2 |
